These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 36409990)

  • 1. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of postmenopausal virilization.
    Alpañés M; González-Casbas JM; Sánchez J; Pián H; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2584-8. PubMed ID: 22669303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperandrogenism after menopause: Ovarian or adrenal origin?].
    Sarfati J; Moraillon-Bougerolle M; Christin-Maitre S
    Gynecol Obstet Fertil Senol; 2022 Oct; 50(10):675-681. PubMed ID: 35609786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to androgen excess in women: Clinical and biochemical insights.
    Cussen L; McDonnell T; Bennett G; Thompson CJ; Sherlock M; O'Reilly MW
    Clin Endocrinol (Oxf); 2022 Aug; 97(2):174-186. PubMed ID: 35349173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
    Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience.
    Luque-Ramírez M; Nattero-Chávez L; Rodríguez-Rubio Corona C; Ortiz-Flores AE; García-Cano AM; Rosillo Coronado M; Pérez Mies B; Ruz Caracuel I; Escobar-Morreale HF
    J Endocrinol Invest; 2024 Aug; 47(8):2007-2020. PubMed ID: 38349517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperandrogenism after menopause.
    Markopoulos MC; Kassi E; Alexandraki KI; Mastorakos G; Kaltsas G
    Eur J Endocrinol; 2015 Feb; 172(2):R79-91. PubMed ID: 25225480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of hyperandrogenism: clinical criteria.
    Yildiz BO
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):167-76. PubMed ID: 16772149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex steroids on women's health: implications for practitioners.
    Derman RJ
    Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.
    Pelusi C; Forlani G; Zanotti L; Gambineri A; Pasquali R
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):533-8. PubMed ID: 22583337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.